NewAmsterdam Pharma And Piramal Pharma Solutions Invest Multi-Million Dollars In Dedicated Oral Solid Dosage Suite At Sellersville Pennsylvania Facility
Benzinga Newsdesk 1 year ago
News
The multi-million-dollar investment provides NewAmsterdam Pharma with commercial capacity for fixed dose combination (FDC) of obicetrapib and ezetimibe to meet potentially high commercial demand.Piramal Pharma Solutions
- The multi-million-dollar investment provides NewAmsterdam Pharma with commercial capacity for fixed dose combination (FDC) of obicetrapib and ezetimibe to meet potentially high commercial demand.
- Piramal Pharma Solutions harnessed the strength of two additional facilities to efficiently produce the FDC, demonstrating the advantages of its integrated approach to development.